Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

12th Tumor Models Boston

Evvnt Promotion / evvnt
-
23.07.2024 - 24.07.2024  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Temi della conferenza
In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery.
Professional congress organizer (PCO)
Hanson Wade Group
Annotazioni
Brochure: https://go.evvnt.com/2397551-3?pid=4832

Speakers: Alexander Adler, Principal Scientist and Research Associate, Regeneron Pharmaceuticals Inc, Alina Ainbinder, Principal Scientist, Takeda Pharmaceuticals Co. Ltd., and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2397551-2?pid=4832
Mr. Alex Domingo
 
Categorie
Oncologia
Lingua
Inglese
Quote del Congresso
Drug Developer, Researchers and Academic - 2 Day Conference Pass: USD 0.50, Solution Provider - 2 Day Conference Pass: USD 3699.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienCenter of ExcellenceÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthÄrzte der Welt